Skip to content
10-Q

Quarterly Report

Bone Biologics Corp BBLG BBLGW

0001641172-25-009746

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 3.27M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $251.16K
Current Liabilities Q1 2025 · Dec 31, 2024 $377.71K
Total Liabilities Q1 2025 · Mar 31, 2025 $251.16K
Total Liabilities Q1 2025 · Dec 31, 2024 $377.71K
Current Assets Q1 2025 · Mar 31, 2025 $3.16M
Current Assets Q1 2025 · Dec 31, 2024 $3.86M
Total Assets Q1 2025 · Mar 31, 2025 $3.16M
Total Assets Q1 2025 · Dec 31, 2024 $3.86M
Shares Diluted Q1 2025 · Mar 31, 2024 660.93K sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.3M
Stockholders Equity Q1 2025 · Mar 31, 2024 $3.67M
Stockholders Equity Q1 2025 · Dec 31, 2023 $2.91M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.31
Eps Basic Q1 2025 · Mar 31, 2024 −$1.31
Sga Expense Q1 2025 · Mar 31, 2024 $657.91K
Rd Expense Q1 2025 · Mar 31, 2024 $245.63K
Net Income Q1 2025 · Mar 31, 2024 −$865.97K
Operating Income Q1 2025 · Mar 31, 2024 −$903.54K